Country-specific Reference Values for PROMIS Pain, Physical Function and Participation Measures Compared to US Reference Values
Overview
Authors
Affiliations
Introduction: Patient-Reported Outcomes Measurement Information System (PROMIS) is commonly used across medical conditions. To facilitate interpretation of scores across countries, we calculated Dutch reference values for PROMIS Physical Function (PROMIS-PF), Pain Interference (PROMIS-PI), Pain Behavior (PROMIS-PB), Ability to Participate in Social Roles and Activities (PROMIS-APSRA), and Satisfaction with Social Roles and Activities (PROMIS-SSRA), as compared to US reference values.
Patients And Methods: A panel completed full PROMIS-PF (=1310), PROMIS-PI and PROMIS-PB (=1052), and PROMIS-APSRA and PROMIS-SSRA (=1002) item banks and reported their level of health per domain (no, mild, moderate, severe limitations). T-scores were calculated by sample and subgroups (age, gender, self-reported level of domain). Distribution-based and anchor-based thresholds for mild, moderate, and severe scores were determined.
Results: Mean T-scores were close to the US mean of 50 for PROMIS-PF (49.8) and PROMIS-APSRA (50.6), lower for PROMIS-SSRA (47.5) and higher for PROMIS-PI (54.9) and PROMIS-PB (52.0). Distribution-based thresholds for mild, moderate, and severe scores were comparable to US recommended cut-off values (except for PROMIS-PI) but participants reported limitations 'earlier' than suggested thresholds.
Conclusion: Dutch reference values were close to US reference values for some PROMIS domains but not all. We recommend country-specific reference values to facilitate worldwide PROMIS use.KEY MESSAGESPROMIS offers universally applicable IRT-based efficient and patient-friendly measures to assess commonly relevant patient-reported outcomes across medical conditions.To support the use of PROMIS in daily clinical practice and research across the world, country-specific general population reference values should be obtained.More research is necessary to obtain reliable and valid cut-off values for what constitutes mild, moderate and severe scores from the patients' perspective.
Patient-reported outcomes in conservatively managed cerebral cavernous malformations.
Sandmann A, Kempeneers M, van den Berg R, Vandertop W, Verbaan D, Coutinho J J Neurol. 2024; 272(1):12.
PMID: 39666180 DOI: 10.1007/s00415-024-12805-3.
Tahir O, de Jonge R, Pronk J, Goei S, Terwee C, van Furth A Eur J Pediatr. 2024; 183(12):5441-5453.
PMID: 39424640 PMC: 11527968. DOI: 10.1007/s00431-024-05819-6.
van Hoorn E, Willems S, Al Arashi W, de Moor A, van Kwawegen C, Teela L Res Pract Thromb Haemost. 2024; 8(4):102474.
PMID: 39076727 PMC: 11284954. DOI: 10.1016/j.rpth.2024.102474.
Luijten M, Haverman L, Terwee C, Poeze M, Verbeek D J Orthop Trauma. 2024; 38(7):390-396.
PMID: 38837210 PMC: 11146170. DOI: 10.1097/BOT.0000000000002814.
Williams G, Flens G, Terwee C, de Beurs E, Spinhoven P, Paap M Qual Life Res. 2024; 33(8):2129-2144.
PMID: 38780673 PMC: 11286634. DOI: 10.1007/s11136-024-03666-4.